塑造药物发现和开发的工具
Eugene Cheung1, Yan Xia1, Marc A Caporini1
1Moderna, 200 Technology Square, Cambridge, Massachusetts 02139, USA.
Biophysics reviews
|March 20, 2024
概括
生物物理方法,如光谱和散射,对于分析制药和生物制药疗法至关重要. 调整这些技术可以确保药物质量和开发新的模式,如mRNA疫苗.
科学领域:
- * 药物和生物制药研究中的生物物理特征.
- *在药物开发中应用先进的分析技术.
背景情况:
- * 传统的方法,如核磁共振 (NMR) 和光光谱,用于识别,纯度分析和研究复杂的生物系统.
- *散射方法 (小角度X射线散射和中子散射) 越来越多地用于反应机制和组件定位.
- * 原子力显微镜 (AFM) 提供了互补和直角测量,特别是在纳米力学中.
研究的目的:
- *审查各种生物物理方法在制药和生物制药研究中的实用性.
- * 突出这些技术在药物开发中的最新应用.
- *强调需要一种不断发展的新疗法特征化工具箱.
主要方法:
- *光谱技术:核磁共振 (NMR) 光谱,光光谱.
- *散射技术:小角度X射线散射 (SAXS),小角度中子散射 (SANS).
- *成像技术:原子力显微镜 (AFM).
主要成果:
- *生物物理方法对于确保各种类型药物的质量至关重要,从小分子到生物制剂和mRNA疫苗.
- *这些技术能够对复杂生物系统中的动态,结构和机制进行详细的分析.
- *先进的散射实验为反应动力学和成分分布提供了洞察力.
- * AFM通过提供纳米机械信息来补充其他方法.
结论:
- * 一个全面的生物物理特性工具箱对于现代药物发现和开发至关重要.
- * 为了应对新治疗方式的复杂性,必须适应已有的光谱方法并采用新技术.
- * 本次审查展示了整合多种生物物理技术的力量,以挑战药物开发场景.
相关概念视频
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
Drug Administration and Therapy Phases: Overview
460
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
460
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K


